To gain insight into the possible role of the CXCL12/CXCR4/CXCR7 axis in tumor development and progression, we explored any association between the expression of the two receptors, or of their ligand, and the clinical characteristics of ACC patients (see Table 1). This evidence concerns the gene CXCR4 and adrenal cortex carcinoma.